Upregulation of miRNA17 was an indicator of poor prognosis in rectal cancer patients54, and in colon cancer cells through targeting Par455, vimentin56, and CCNG2 in recurrent head and neck squamous cell carcinoma57. Here, CCNG2 is linked to rectal cancer.